Takings issues in the approval of generic biologics

被引：0

|

作者：

Yoo, JC ^{[1
]}

机构：

[1] Univ Calif Berkeley, Boalt Hall Sch Law, Berkeley, CA 94720 USA

来源：

FOOD AND DRUG LAW JOURNAL | 2005年 / 60卷 / 01期

关键词：

D O I：

暂无

中图分类号：

TS2 [食品工业];

学科分类号：

0832 ;

摘要：

引用

收藏

页码：33 / 43

页数：11

相关论文

共 50 条

[41] US biotech prepares to fight generic biologics
Reid, B
NATURE BIOTECHNOLOGY, 2002, 20 (04) : 322 - 322
[42] Generic biologics poised to enter US and EU
Watts, J
Thompson, J
Varnau, M
GENETIC ENGINEERING NEWS, 2004, 24 (12): : 10 - 12
[43] FDA caution tempers race for generic biologics
Warner, S
SCIENTIST, 2003, 17 (20): : 44 - 45
[44] Producers and regulators gear up for generic Biologics
West, D
CHEMICAL WEEK, 2003, 165 (38) : 29 - 29
[45] Approval plans: Issues and innovations
Chvatal, DP
PUBLISHING RESEARCH QUARTERLY, 1997, 13 (03) : 124 - 125
[46] EMA perspective on approval issues
Gravanis, I.
EUROPEAN JOURNAL OF CANCER, 2013, 49 : S4 - S4
[47] Approval plans: Issues and innovations
Winzenried, A
ELECTRONIC LIBRARY, 1998, 16 (03): : 209 - 209
[48] Parsing the Generic-Drug Approval Process
Terrie, Yvette
US PHARMACIST, 2018, : 10 - +
[49] ISSUES OF GENERIC SUBSTITUTION
KNAPP, G
FOOD AND DRUG LAW JOURNAL, 1979, 34 (02): : 98 - 102
[50] Harmonizing marketing approval of generic drugs in Europe: Regulatory agencies in Europe are working to harmonize the marketing approval pathway of generic medicines
Milmo, Sean
Pharmaceutical Technology, 2014, 38 (10) : 22 - 24

← 1 2 3 4 5 →